Triomics
AI Agents for Oncology EHRs
About
Triomics is building the AI infrastructure for modern oncology. Across the U.S., cancer care providers rely on highly trained staff to manually review unstructured patient records such as pathology reports, clinical notes, genomic panels, and scanned faxes to support workflows like clinical trial matching, visit preparation, and quality reporting. We replace that manual work with task-driven AI agents embedded directly into clinical workflows, automatically processing medical records at scale and in real time. Our platform is trusted by 4 of the top 10 Best Hospitals for Cancer ranked by U.S. News, as well as several of the largest community oncology practices.
Founders
- Sarim Khan
Family Office Investors
Altss tracks family office allocations to YC-backed companies. Request access to see which family offices have invested in Triomics.
See family office activity